Weston Family Nears $9B Boots Acquisition

The influential Canadian Weston family, through its investment arm Wittington Investments, is reportedly nearing a significant acquisition of the UK chemist chain Boots. Sources indicate the deal could value the business at approximately $9 billion. This potential transaction marks a pivotal moment for Sycamore Partners, the private equity firm that currently holds Boots as part of its broader portfolio following its acquisition of Walgreens Boots Alliance.

Sycamore Partners has been strategically dismantling the Walgreens Boots Alliance conglomerate, carving it into five distinct entities, each positioned for individual divestment. The sale of Boots would represent a major realization event for the private equity sponsor. While Wittington Investments has emerged as the frontrunner, Sycamore had previously explored discussions with other potential suitors, including Australia's Sigma Healthcare, underscoring the strategic interest in the well-established retail pharmacy brand.

The proposed acquisition by the Weston family, a dynasty with deep roots in UK retail, including ownership of Primark and Fortnum & Mason, would signify a notable return to the British market after their divestment of Selfridges four years ago. Wittington Investments also holds substantial interests in Canadian enterprises such as the grocery giant Loblaws and the pharmacy network Shoppers Drug Mart, suggesting a strategic alignment with the pharmacy sector.

Recent performance indicators for Boots have shown resilience, potentially bolstering its valuation. The company reported a 3.2% increase in revenue to £7.5 billion for the year ending August 2025, alongside a 25% jump in pre-tax profit to £337 million. This improvement, partly attributed to reversed impairment charges and a surge in demand for beauty products and weight-loss treatments, contrasts with earlier challenges when Walgreens initially attempted to offload the chain in 2022, facing bids that did not meet expectations.

A definitive agreement would likely preclude an initial public offering (IPO) on the London Stock Exchange, a path that had been anticipated by some market observers, particularly following the appointment of former Currys CEO Alex Baldock to lead Boots. The finalization of this deal would also bring an end to a prolonged period of ownership uncertainty surrounding the iconic British brand.

The proceeds from the sale are expected to be shared with the family of Stefano Pessina, who orchestrated the merger of Boots and Walgreens in 2012 and retains a significant 44% stake in the divested entities. The transaction, if completed, would underscore the ongoing trend of private equity-driven portfolio restructuring and strategic asset sales within the consumer and retail sectors, a market segment that continues to attract substantial capital.